Cula Svidzinski
Dermatology · New York, NYNPI 1437685401
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by AbbVie at 39.6% of the total. Reporting peaked in 2022 at $3,689 and has fallen 99.4% since, to $22 in 2025.
Across 162 payments — averaging $60.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Sanofi$3K
- Johnson & Johnson$847
- Novartis$378
- Merz North America, Inc.$333
- Galderma Laboratories, L.p.$261
- plus $953 from 14 others
Across 3 payments — averaging $27,707 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$83K
What the payments were for
- Consulting fees$2,87529%
- Travel & lodging$2,21423%
- Food & beverage$4,46546%
- Education$1902%
- Gifts$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 52 | $3,872 |
| Sanofi | 11 | $3,133 |
| Johnson & Johnson | 31 | $847 |
| Novartis | 13 | $378 |
| Merz North America, Inc. | 3 | $333 |
| Galderma Laboratories, L.p. | 13 | $261 |
| Pfizer | 8 | $200 |
| Lilly USA, LLC | 9 | $196 |
| Sanofi-aventis U.S. LLC | 3 | $147 |
| Regeneron Healthcare Solutions, Inc. | 4 | $105 |
| LEO Pharma Inc. | 3 | $69 |
| Amgen | 2 | $58 |
| VYNE Pharmaceuticals Inc. | 1 | $30 |
| Fidia Pharma USA Inc. | 1 | $24 |
| Journey Medical Corporation | 1 | $24 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $22 |
| UCB, Inc. | 1 | $22 |
| Genentech USA, Inc. | 3 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Incyte Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,778 in reported general payments places this provider in the 75th percentile of 1,151 dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 13 | $152 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.